姜一笑
Lv12
40 积分
2020-10-22 加入
-
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
2小时前
求助中
-
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
12小时前
已完结
-
Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial
2个月前
已完结
-
Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial
2个月前
已完结
-
Immunotherapy in NSCLC patients with brain metastases. Understanding brain tumor microenvironment and dissecting outcomes from immune checkpoint blockade in the clinic
6个月前
已完结
-
Tight junctions and human diseases
3年前
已完结
-
Amplified fluorescence detection and adsorption of Au3+ by the fluorescent melamine formaldehyde microspheres incorporated with N and S co-doped carbon dots
3年前
已完结
-
Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma
4年前
已完结
-
Possibilities of reducing the doses of beta-adrenergic bronchodilators (Berotec) in combination with an anticholinergic drug (Atrovent) in bronchial asthma
4年前
已关闭
-
Nébulisation dans l'asthme aigu Intérêt de l'association d'un atropinique et d'un bêta2-sympathomimétique
4年前
已完结